CAV1 and pulmonary fibrosis: In SSc‐ILD patients, Cav‐1 expression is diminished in leukocytes, particularly in PMNs and monocytes/macrophages, resulting in altered signaling pathways that drive the advancement of pulmonary fibrosis [95].